Skip to main content

belinostat

Generic: BELINOSTAT·Brand: BELEODAQ

belinostat: 3 clinical trials tracked.

belinostat evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about belinostat, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trials (3)

Phase 1 Investigation of Belinostat-Based Combinations in Relapsed/Refractory T-Cell Lymphoma

NCT07691450·Phase 1
Not yet recruiting

Primary endpoint: Occurrence of dose-limiting toxicities (DLT) (Arm A)

Interventionalopen40 targetStarted 2027-01Completion 2029-111 site · United StatesCity of Hope Medical Center

A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physician's Choice Standard of Care Treatment (Selected Single Agent) in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

NCT06561048·Phase 3·CRVS
Recruiting

Primary endpoint: Progression-free survival

InterventionalRandomizedopen150 targetStarted 2024-10Completion 2028-1234 sites · Australia, Canada, United StatesCorvus Pharmaceuticals, Inc.

A Phase II Study of Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

NCT05170334·Phase 2
Active, not recruiting

Primary endpoint: Overall Response Rate

Interventionalopen7 targetStarted 2021-12Completion 2028-011 site · United StatesH. Lee Moffitt Cancer Center and Research Institute